Tag Mitchel P. Goldman

Clinical Methods for Sclerotherapy of Telangiectasias

Historical Review of Techniques Sclerosing treatment for telangiectasias was ignored until the 1930s, when Biegeleisen injected sclerosing agents intradermally or subcutaneously into the general area of capillary enlargement. However, this procedure caused severe necrosis and lacked effect on the telangiectasias.…

Phlebology and Treatment of Leg Veins

Key features ■ Superficial telangiectasias, reticular veins, and varicose veins of the lower extremities are interconnected and develop after impairment of venous return ■ Poor venous return results from venous valvular incompetence or primary muscle pump failure ■ A pretreatment…

Mechanism of Action of Sclerotherapy

General Mechanism for Producing Endothelial Damage Sclerotherapy refers to the introduction of a foreign substance into the lumen of a vessel, aiming to create venous wall damage leading to occlusion of the vessel ( Fig. 7.1 ). This procedure, when…

Pathophysiology of Telangiectasias

The term telangiectasia was coined in 1807 by Von Graf to describe a superficial vessel of the skin visible to the human eye. These vessels measure 0.1–1 mm in diameter and represent an expanded venule, capillary or arteriole. Telangiectasias that originate…

Pathophysiology of Varicose Veins

Essentially, three components of the venous system of the leg act in concert: deep veins, superficial veins and perforating-communicating veins. Dysfunction in any of these three systems results in dysfunction of the other two ( Fig. 3.1 ). When the…